(VIANEWS) – New York Community Bancorp (NYCB), Ladder Capital Corp (LADR), Amphastar Pharmaceuticals (AMPH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. New York Community Bancorp (NYCB)
129.7% sales growth and 28.27% return on equity
New York Community Bancorp, Inc. operates as a bank holding company for New York Community Bank that provides banking products and services in Metro New York, New Jersey, Ohio, Florida, and Arizona. The company offers various deposit products, including interest-bearing checking and money market, savings, non-interest-bearing, and individual retirement accounts, as well as certificates of deposit. It also provides multi-family loans; commercial real estate loans; specialty finance loans and leases, and other commercial and industrial loans; acquisition, development, and construction loans; one-to-four family loans; and consumer loans. In addition, the company offers annuities, life and long-term care insurance products, and mutual funds; cash management products; and online, mobile, and phone banking services. It primarily serves individuals, small and mid-size businesses, and professional associations through a network of 238 community bank branches and 348 ATM locations. The company was formerly known as Queens County Bancorp, Inc. and changed its name to New York Community Bancorp, Inc. in November 2000. New York Community Bancorp, Inc. was founded in 1859 and is headquartered in Westbury, New York.
Earnings Per Share
As for profitability, New York Community Bancorp has a trailing twelve months EPS of $3.82.
PE Ratio
New York Community Bancorp has a trailing twelve months price to earnings ratio of 2.79. Meaning, the purchaser of the share is investing $2.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.27%.
Sales Growth
New York Community Bancorp’s sales growth is 117.2% for the current quarter and 129.7% for the next.
2. Ladder Capital Corp (LADR)
39.5% sales growth and 11.08% return on equity
Ladder Capital Corp operates as a real estate investment trust in the United States. The company operates through three segments: Loans, Securities, and Real Estate. The Loans segment originates conduit first mortgage loans that are secured by cash-flowing commercial real estate; and originates and invests in balance sheet first mortgage loans secured by commercial real estate properties that are undergoing transition, including lease-up, sell-out, and renovation or repositioning. It also invests in note purchase financings, subordinated debt, mezzanine debt, and other structured finance products related to commercial real estate. The Securities segment invests in commercial mortgage-backed securities and the U.S. Agency Securities. This segment also invests in corporate bonds and real estate related equity investments. The Real Estate segment owns and invests in a portfolio of commercial and residential real estate properties, such as leased properties, student housing portfolio, industrial buildings, office buildings, shopping center, and condominium units. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Ladder Capital Corp has a trailing twelve months EPS of $1.16.
PE Ratio
Ladder Capital Corp has a trailing twelve months price to earnings ratio of 8.89. Meaning, the purchaser of the share is investing $8.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.08%.
Yearly Top and Bottom Value
Ladder Capital Corp’s stock is valued at $10.31 at 16:22 EST, way under its 52-week high of $12.18 and way higher than its 52-week low of $8.67.
Revenue Growth
Year-on-year quarterly revenue growth declined by 17.1%, now sitting on 331.99M for the twelve trailing months.
Moving Average
Ladder Capital Corp’s worth is above its 50-day moving average of $9.66 and above its 200-day moving average of $10.24.
3. Amphastar Pharmaceuticals (AMPH)
30.3% sales growth and 18.12% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $1.74.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 31.97. Meaning, the purchaser of the share is investing $31.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.12%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amphastar Pharmaceuticals’s EBITDA is 5.05.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 354616 which is 20.46% below its average volume of 445875.
4. Perion Network Ltd (PERI)
16.8% sales growth and 19.59% return on equity
Perion Network Ltd. provides digital advertising solutions to brands, agencies, and publishers in North America, Europe, and internationally. It provides Wildfire, a content monetization platform; search monetization solutions, including website monetization, search mediation, and app monetization; and cross-channel digital advertising software as a service platform. The company also offers supply management platform; demand management platform for campaign planning and design; analytics platform, which provides information and performance insights on the results of campaign investment and other campaign metrics; creative platform to create advertisements; and an AI platform that uses machine learning to bring intelligence to the various phases of campaigns. In addition, it provides an actionable performance monitoring platform to support the various phases of campaign management; an online video player and integrated ad server to upload, manage, and stream video content; content monetization system, which integrates ads within the content layouts at the page level. Further, the company offers a publisher management system that provides analytics and performance optimization tools, as well as reports; search-demand management systems; monetization products that integrate and onboards demand vendors; and AI Systems. Additionally, it provides Intelligent HUB (iHUB), a platform for pulling in signals across various advertising channels and optimizing traffic at scale, and yielding engagement metrics and KPIs; and strategic optimization of relevant traits (SORT), a provisional patent technology that eliminates the need for cookies. The company was formerly known as IncrediMail Ltd. and changed its name to Perion Network Ltd. in November 2011. Perion Network Ltd. was incorporated in 1999 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Perion Network Ltd has a trailing twelve months EPS of $2.11.
PE Ratio
Perion Network Ltd has a trailing twelve months price to earnings ratio of 14.54. Meaning, the purchaser of the share is investing $14.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.59%.
Moving Average
Perion Network Ltd’s worth is below its 50-day moving average of $32.92 and higher than its 200-day moving average of $29.98.
Volume
Today’s last reported volume for Perion Network Ltd is 432537 which is 48.06% below its average volume of 832822.
Sales Growth
Perion Network Ltd’s sales growth is 15.8% for the current quarter and 16.8% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Perion Network Ltd’s EBITDA is 49.37.
5. WNS (WNS)
15.6% sales growth and 17.66% return on equity
WNS (Holdings) Limited, a business process management (BPM) company, provides data, voice, analytical, and business transformation services worldwide. The company operates through two segments, WNS Global BPM and WNS Auto Claims BPM. It offers industry-specific services to clients primarily in insurance; diversified businesses, including manufacturing, retail, consumer packaged goods, media and entertainment, and telecom; travel and leisure; healthcare; utilities; shipping and logistics; consulting and professional services; and banking and financial services. It also provides a range of services, such as finance and accounting, customer experience, research and analytics, technology, legal, and human resources outsourcing services. In addition, the company offers transformation services designed to allow its clients to enhance productivity, manage changes in the business environment, and leverage business knowledge to increase market competitiveness. Further, it provides claims handling and repair management services for automobile repairs through a network of third-party repair centers; and a suite of accident management services comprising credit hire and repair. The company was founded in 1996 and is based in Mumbai, India.
Earnings Per Share
As for profitability, WNS has a trailing twelve months EPS of $2.7.
PE Ratio
WNS has a trailing twelve months price to earnings ratio of 26.28. Meaning, the purchaser of the share is investing $26.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.66%.
6. KBR (KBR)
10.6% sales growth and 21.51% return on equity
KBR, Inc. provides professional services and technologies across the asset and program life-cycle within the government services and hydrocarbons industries worldwide. The company operates through three segments: Government Solutions, Technology Solutions, and Energy Solutions. The Government Solutions segment offers life-cycle support solutions to defense, space, aviation, and other programs and missions for military and other government agencies in the United States, the United Kingdom, and Australia. This segment's services cover from research and development, through systems engineering, test and evaluation, systems integration and program management, to operations support, maintenance, and field logistics. The Technology Solutions segment provides proprietary technologies, equipment and catalyst supply, digital solutions and associated knowledge-based services into a global business for refining, petrochemicals, inorganic, and specialty chemicals, as well as gasification, syngas, ammonia, nitric acid and fertilizers. The Energy Solutions segment offers life-cycle support solutions across the upstream, midstream, and downstream hydrocarbons markets; comprehensive project and program delivery solutions, as well as engineering services, front-end consulting and feasibility studies, sustaining capital construction, turnarounds, maintenance services, and others. This segment provides EPC, and consulting and engineering services for onshore oil and gas; LNG/GTL; oil refining; petrochemicals; chemicals; fertilizers; offshore oil and gas; and floating solutions. KBR, Inc. was founded in 1901 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, KBR has a trailing twelve months EPS of $2.26.
PE Ratio
KBR has a trailing twelve months price to earnings ratio of 27.71. Meaning, the purchaser of the share is investing $27.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.51%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
KBR’s EBITDA is 1.53.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.6%, now sitting on 6.55B for the twelve trailing months.
Moving Average
KBR’s value is above its 50-day moving average of $59.77 and way higher than its 200-day moving average of $53.00.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 0.54 and the estimated forward annual dividend yield is 0.84%.
7. ITT Corporation (ITT)
8.1% sales growth and 18.01% return on equity
ITT Inc. manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates through three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components; and sealing technologies primarily for the transportation industry, including passenger cars, light- and heavy-duty commercial and military vehicles, buses, and rail. The Industrial Process segment designs and manufactures industrial pumps, valves, and plant optimization systems; and centrifugal process pumps, twin screw, axials, and positive displacement pumps, and water systems, as well as aftermarket solutions, such as repairs and upgrades services. It serves various customers in industries, such as chemical, oil and gas, mining, and other industrial process markets. The Connect & Control Technologies segment designs and manufactures a range of engineered connectors and specialized control components for critical applications supporting various markets, including aerospace and defense, industrial, transportation, medical, and oil and gas. The connector product portfolio includes electrical connectors, such as circular, rectangular, radio frequency, fiber optic, D-sub miniature, micro-miniature, and cable assemblies; and control products consist of fuel and water pumps, valves, electro-mechanical rotary and linear actuators, and pressure, temperature, limit, and flow switches for various aircraft systems. ITT Inc. was founded in 1920 and is headquartered in White Plains, New York.
Earnings Per Share
As for profitability, ITT Corporation has a trailing twelve months EPS of $4.72.
PE Ratio
ITT Corporation has a trailing twelve months price to earnings ratio of 18.45. Meaning, the purchaser of the share is investing $18.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.01%.
